Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CAR-MSC

Home DrugsCAR-MSC

CAR-MSC

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING OF MSC CELLS
EP 4065138 A4Applicant: UNIV TEXASPriority: 2019
CN
EP
US
WO
4 publications
GENETICALLY MODIFIED MESENCHYMAL STEM CELLS EXPRESSING AN IMMUNE RESPONSE-STIMULATING CYTOKINE TO ATTRACT AND/OR ACTIVATE IMMUNE CELLS
EP 3656387 A3Applicant: APCETH GMBH & CO KGPriority: 2014
CN
EP
2 publications
Method for treating side effect of chimeric antigen receptor (CAR) T cell therapy
CN 110678191 AApplicant: CYNATA THERAPEUTICS LTDPriority: 2017
CN
一种治疗肿瘤的药物组合
- CN 107184603 B
  Applicant: 刘未斌Priority: 2017
  CN
- CN 107184602 B
  Applicant: 刘未斌Priority: 2017
  CN
MSC-EXPRESSED IMMUNOMODULATORS IN COMBINATION WITH CAR-T FOR CANCER THERAPY
CN 111386123 AApplicant: BRIGHAM & WOMENS HOSPITAL INCPriority: 2017
CN
Instrument for treating gastrointestinal tumors by CAR-T
CN 111346290 AApplicant: BAYANNUR HOSPITALPriority: 2020
CN
药物组合制剂在制备治疗2019-nCoV感染重症患者药物中的应用
CN 113230275 BApplicant: 北京呈诺医学科技有限公司Priority: 2021
CN
一种脐带间充质干细胞外泌体的制备方法及其应用
CN 114990068 BApplicant: 郑州大学第一附属医院Priority: 2022
CN
CAR and CAR-M cells targeting hepatocellular carcinoma and construction method and application thereof
CN 118530370 AApplicant: THE SEVENTH AFFILIATED HOSPITAL SUN YAT SEN UNIV SHENZHENPriority: 2024
CN
CAR-MSC (chimeric antigen receptor-mesenchymal stem cell) targeting fibroblast activating protein as well as preparation method and application of CAR-MSC
CN 119859615 AApplicant: GUANGZHOU ANJIE BIOMEDICAL TECH CO LTDPriority: 2024
CN